Atlas Trials

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Clinical trial NCT07736937 · RECRUITING

Trial details

NCT number
NCT07736937
Sponsor
Tubulis GmbH
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2026-03-30
Primary completion
2028-03-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.